secwatch.observer — SEC 8-K summary
======================================

Issuer:     CODEXIS, INC. (CDXS)
CIK:        0001200375
Form:       8-K
Filed at:   2025-05-14T23:59:59+00:00
Accession:  0001193125-25-119847
Event type: earnings
Sentiment:  negative
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Codexis Q1 revenue drops to $7.5M from $17.1M; net loss widens to $20.7M
------------------------------------------------------------------------

- Revenue $7.5M vs $17.1M in Q1 2024; decline due to $6M one-time Roche license and large orders in prior year.
- Net loss $20.7M ($0.25/share) vs $11.5M ($0.16/share) in Q1 2024; R&D expenses up to $12.9M.
- Cash $59.8M; expects to fund operations through positive cash flow by end 2026.
- Reiterates FY 2025 revenue guidance of $64M-$68M; secured first revenue contract for ECO Synthesis manufacturing.
- Appointed Christos Richards and Cynthia Collins to board; Arthur Levin to Strategic Advisory Board.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1200375/000119312525119847/0001193125-25-119847-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1200375/000119312525119847/d949323d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-119847

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer